Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Mercer Intl's Ex-Dividend Date Is Tuesday, Here's What You Need To Know

Monday marks the last chance for investors to receive the next dividend payout from Mercer Intl (NASDAQ:MERC).

Benzinga

Ituran Location & Control: Dividend Insights

Monday marks the last chance for investors to receive the next dividend payout from Ituran Location & Control (NASDAQ:ITRN).

Benzinga

Why Netflix Is Launching An Ad-Supported Streaming Plan

Streaming giant Netflix Inc (NASDAQ: NFLX) has had a change of heart when it comes to ad-supported streaming. CEO Ted Sarandos shared why the company is moving forward with the new plan.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Check Out What Whales Are Doing With COST

A whale with a lot of money to spend has taken a noticeably bullish stance on Costco Wholesale. Looking at options history for Costco Wholesale (NASDAQ:COST) we detected 14 strange trades.

Benzinga

The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Check Out What Whales Are Doing With BKNG

A whale with a lot of money to spend has taken a noticeably bearish stance on Booking Holdings. Looking at options history for Booking Holdings (NASDAQ:BKNG) we detected 30 strange trades.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2022

Upgrades

Benzinga

Read news from The Economist, FT, and more,
with one subscription

U.S. Markets Open Higher; Jobless Claims Drop To 229,000

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 200 points on Thursday.

Benzinga

Ulta Beauty's Return On Capital Employed Overview

According to Benzinga Pro, during Q1, Ulta Beauty (NASDAQ:ULTA) earned $331.39 million, a 14.52% increase from the preceding quarter. Ulta Beauty's sales decreased to $2.35 billion, a 14.03% change since Q4.

Benzinga

Workday Earnings Perspective: Return On Capital Employed

Benzinga Pro data, Workday (NASDAQ:WDAY) reported Q1 sales of $1.44 billion. Earnings fell to a loss of $102.17 million, resulting in a 39.48% decrease from last quarter.

Benzinga

Dollar Tree's Return on Invested Capital Overview

Pulled from Benzinga Pro data, Dollar Tree (NASDAQ:DLTR) posted Q1 earnings of $536.40 million, an increase from Q4 of 18.1%. Sales dropped to $6.90 billion, a 2.51% decrease between quarters.

Benzinga

Looking Into Amerco's Return On Capital Employed

Pulled from Benzinga Pro data, Amerco (NASDAQ:UHAL) posted Q4 earnings of $86.75 million, an increase from Q3 of 69.18%. Sales dropped to $1.20 billion, a 14.67% decrease between quarters.

Benzinga

Intuit's Return On Capital Employed Insights

According to Benzinga Pro, during Q3, Intuit (NASDAQ:INTU) earned $1.79 billion, a 1694.0% increase from the preceding quarter. Intuit also posted a total of $5.63 billion in sales, a 110.7% increase since Q2.

Benzinga

Star Equity Holdings's Return On Capital Employed Overview

According to Benzinga Pro data, during Q1, Star Equity Holdings (NASDAQ:STRR) posted sales of $25.05 million. Earnings were up 16.23%, but Star Equity Holdings still reported an overall loss of $3.70 million.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Looking Into ThermoGenesis Holdings's Return On Capital Employed

According to Benzinga Pro data, during Q1, ThermoGenesis Holdings (NASDAQ:THMO) posted sales of $2.66 million. Earnings were up 29.45%, but ThermoGenesis Holdings still reported an overall loss of $2.04 million.

Benzinga

Why Apogee Enterprises Shares Are Gaining Today

Apogee Enterprises Inc (NASDAQ:APOG) reported first-quarter FY23 sales growth of 9% year-over-year to $356.6 million, beating the consensus of $328.59 million. Revenue by segments: Architectural Framing Systems $163.3 million (+19% Y/Y); Architectural Glass $76.3 million (-8.1% Y/Y); Architectural Services $103.4 million (+14% Y/Y); and Large-Scale Optical $25.2 million (+4% Y/Y). The gross…

Benzinga

View Clocks 74% Revenue Growth In Q1; Reaffirms FY22 Forecast

View, Inc (NASDAQ:VIEW) reported first-quarter FY22 revenue growth of 74% year-on-year to $17 million, beating the consensus of $15.1 million. The continued traction of the newly introduced Smart Building Platform offering and the growth of Smart Building Technologies products drove the increase. EPS loss of $(0.38) missed the consensus loss of $(0.24). View…

Benzinga

Polestar SPAC Gores Guggenheim Is Higher: Here's Why

Shares of special purpose acquisition company Gores Guggenheim Inc (NASDAQ: GGPI) are moving higher Thursday after shareholders approved its proposed business combination with Swedish EV company Polestar.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Where TripAdvisor Stands With Analysts

Analysts have provided the following ratings for TripAdvisor (NASDAQ:TRIP) within the last quarter:

Benzinga

14 Analysts Have This to Say About Airbnb

Within the last quarter, Airbnb (NASDAQ:ABNB) has observed the following analyst ratings:

Benzinga

Analyst Ratings for Latham Group

Latham Group (NASDAQ:SWIM) has observed the following analyst ratings within the last quarter:

Benzinga

Expert Ratings for Marathon Digital Holdings

Within the last quarter, Marathon Digital Holdings (NASDAQ:MARA) has observed the following analyst ratings:

Benzinga

Traders See Bumpy Road Ahead For Gilead Sciences

Gilead Sciences, Inc. (NASDAQ: GILD) climbed on Wednesday, even as the S&P 500 ended the day with losses.

Benzinga

Biden Administration Reportedly Approached Tesla On Its Day 1 In Office: What Was It About?

Tesla, Inc. (NASDAQ: TSLA) was reportedly approached by President Joe Biden's administration to help with drafting a new renewable energy policy.

Benzinga

Aura Biosciences' Belzupacap Sarotalocan At Par With Plaque Radiotherapy In Eye Cancer

Aura Biosciences Inc (NASDAQ:AURA) reported data from a retrospective analysis that assessed the visual acuity after plaque radiotherapy treatment compared with prospective data in early-stage choroidal melanoma patients treated with belzupacap sarotalocan by intravitreal administration in the Phase 1b/2 trial. The vision results of patients with early-stage choroidal melanoma treated with radiotherapy showed…

1 … 265 266 267 268

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.